Search

Author/Creator Naylor, Maria L

1. 069 Peginterferon beta-1a improves clinical and radiological disease outcomes in patients who are newly diagnosed with relapsing-remitting multiple sclerosis (RRMS): subgroup analysis of advance. Issue 6 (24th May 2018)

Authors:
Newsome, Scott D; Arnold, Douglas L; Yun, Jang; Meergans, Matthias; Naylor, Maria L
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP). Issue 6 (24th May 2018)

Authors:
Salvetti, Marco; Yun, Jang; Appiah-Badu, David; Sabatella, Guido; Naylor, Maria L
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. (June 2022)

Authors:
Cohen, Jeffrey A; Bermel, Robert A; Grossman, Cynthia I; Hersh, Carrie M; Hyland, Megan; Mowry, Ellen M; Naismith, Robert; Naylor, Maria L; Nicholas, Jacqueline; Rajbhandar, Rajani; Singh, Carol M; Tintorè, Mar; Zabalza, Ana; Ziemssen, Tjalf; Williams, James R; Montalban, Xavier
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 7(2022)
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗